1. Lu, Charles, Xie, Mingchao, Wendl, Michael C, Parvin, Jeffrey D, Ding, Li. 2015. Patterns and functional implications of rare germline variants across 12 cancer types. In Nature communications, 6, 10086. doi:10.1038/ncomms10086. https://pubmed.ncbi.nlm.nih.gov/26689913/
2. Basbous, Jihane, Constantinou, Angelos. 2019. A tumor suppressive DNA translocase named FANCM. In Critical reviews in biochemistry and molecular biology, 54, 27-40. doi:10.1080/10409238.2019.1568963. https://pubmed.ncbi.nlm.nih.gov/30714416/
3. Abbouche, Lara, Bythell-Douglas, Rohan, Deans, Andrew J. 2024. FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair. In DNA repair, 140, 103701. doi:10.1016/j.dnarep.2024.103701. https://pubmed.ncbi.nlm.nih.gov/38878565/
4. Klarić, Monika Logara, Marić, Tihana, Žunić, Lucija, Belužić, Robert, Katušić Bojanac, Ana. 2024. FANCM Gene Variants in a Male Diagnosed with Sertoli Cell-Only Syndrome and Diffuse Astrocytoma. In Genes, 15, . doi:10.3390/genes15060707. https://pubmed.ncbi.nlm.nih.gov/38927643/
5. Liu, Zeyuan, Jiang, Huadong, Lee, Sze Yuen, Kong, Nannan, Chan, Ying Wai. 2024. FANCM promotes PARP inhibitor resistance by minimizing ssDNA gap formation and counteracting resection inhibition. In Cell reports, 43, 114464. doi:10.1016/j.celrep.2024.114464. https://pubmed.ncbi.nlm.nih.gov/38985669/
6. Neidhardt, Guido, Hauke, Jan, Ramser, Juliane, Schmutzler, Rita K, Hahnen, Eric. . Association Between Loss-of-Function Mutations Within the FANCM Gene and Early-Onset Familial Breast Cancer. In JAMA oncology, 3, 1245-1248. doi:10.1001/jamaoncol.2016.5592. https://pubmed.ncbi.nlm.nih.gov/28033443/
7. Figlioli, Gisella, Billaud, Amandine, Ahearn, Thomas U, Radice, Paolo, Peterlongo, Paolo. 2023. FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. In European journal of human genetics : EJHG, 31, 578-587. doi:10.1038/s41431-022-01257-w. https://pubmed.ncbi.nlm.nih.gov/36707629/
智鼠故事 
